Cellular Biomedicine Group (CBMG) Announces Stock Repurchase Program
Jun 01, 2017 10:04 am UTC| Business
SHANGHAI, China and CUPERTINO, Calif., June 01, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of effective...
Cellular Biomedicine Group (CBMG) Announces Stock Repurchase Program
Jun 01, 2017 10:04 am UTC| Business
SHANGHAI, China and CUPERTINO, Calif., June 01, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of effective...
Cellular Biomedicine Group (CBMG) Announces Stock Repurchase Program
Jun 01, 2017 10:04 am UTC| Business
SHANGHAI, China and CUPERTINO, Calif., June 01, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of effective...
Cellular Biomedicine Group (CBMG) Announces Stock Repurchase Program
Jun 01, 2017 10:04 am UTC| Business
SHANGHAI, China and CUPERTINO, Calif., June 01, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of effective...
Cellular Biomedicine Group (CBMG) Announces Stock Repurchase Program
Jun 01, 2017 10:04 am UTC| Business
SHANGHAI, China and CUPERTINO, Calif., June 01, 2017 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of effective...
Jun 01, 2017 10:03 am UTC| Business
VANCOUVER, Washington, June 01, 2017 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new monoclonal antibody therapies for combating human immunodeficiency virus (HIV) infection,...
Jun 01, 2017 10:03 am UTC| Business
VANCOUVER, Washington, June 01, 2017 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new monoclonal antibody therapies for combating human immunodeficiency virus (HIV) infection,...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows